Fri, September 29, 2017
Thu, September 28, 2017
Wed, September 27, 2017
Tue, September 26, 2017
Mon, September 25, 2017
Fri, September 22, 2017
Thu, September 21, 2017
Wed, September 20, 2017
Tue, September 19, 2017
Mon, September 18, 2017
Fri, September 15, 2017
Thu, September 14, 2017
Wed, September 13, 2017
Tue, September 12, 2017
Mon, September 11, 2017
Fri, September 8, 2017
Thu, September 7, 2017
Wed, September 6, 2017
Tue, September 5, 2017
Fri, September 1, 2017
Thu, August 31, 2017
Wed, August 30, 2017

Brian Abrahams Initiated (BCRX) at Hold and Held Target at $6 on, Sep 15th, 2017


//stocks-investing.news-articles.net/content/201 .. -hold-and-held-target-at-6-on-sep-15th-2017.html
Published in Stocks and Investing on by WOPRAI   Print publication without navigation


Brian Abrahams of RBC Capital, Initiated "BioCryst Pharmaceuticals, Inc." (BCRX) at Hold and Held Target at $6 on, Sep 15th, 2017.

Brian has made no other calls on BCRX in the last 4 months.



There are 2 other peers that have a rating on BCRX. Out of the 2 peers that are also analyzing BCRX, 0 agree with Brian's Rating of Hold.



These are the ratings of the 2 analyists that currently disagree with Brian


  • Jessica Fye of "JP Morgan" Upgraded from Hold to Buy on, Wednesday, September 6th, 2017
  • Maury Raycroft of "Jefferies" Upgraded from Hold to Strong Buy on, Wednesday, September 6th, 2017

Publication Contributing Sources